Why Did Netflix Buy Warner Bros?
Following a bidding war, Netflix (NASDAQ:NFLX) has announced its intention…
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $353M | $448.2M | $464M | $114.1M | $118.8M | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | $90.5M | $100.7M | $112.4M | $25.4M | $28.8M | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | $3.42 | $3.25 | $3.64 | $0.82 | $0.94 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $375.6M | $192.7M | $424M | $207.9M | $321.2M | |
| Total Assets | $6B | $6.7B | $7.9B | $7.6B | $7.8B | |
| Current Liabilities | $1.4B | $1.6B | $1.7B | $1.6B | $1.7B | |
| Total Liabilities | $5.4B | $6.1B | $7.1B | $6.7B | $6.9B | |
| Total Equity | $627.2M | $600.7M | $737.9M | $858.5M | $932.2M | |
| Total Debt | $241.8M | $304.7M | $509.3M | $364.1M | $362.1M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $2.2M | $103.2M | -$2.5M | $33.6M | $33M | |
| Cash From Investing | $391.9M | $113M | -$56.8M | -$30.3M | -$46.2M | |
| Cash From Financing | -$171.8M | -$435.2M | $172.2M | -$74.6M | $100.2M | |
| Free Cash Flow | -$2M | $98.9M | -$8.6M | $32.5M | $31.9M | |
First Mid Bancshares, Inc. is a financial holding company, which engages in the provision of banking services through its subsidiaries. It offers trust, farm services, investment services, and retirement planning. The company was founded on September 8, 1981 and is headquartered in Mattoon, IL.
In the current month, FMBH has received 2 Buy ratings 3 Hold ratings, and 0 Sell ratings. The FMBH average analyst price target in the past 3 months is $44.29.
According to analysts, the consensus estimate is that First Mid Bancshares, Inc. share price will rise to $44.29 per share over the next 12 months.
Analysts are divided on their view about First Mid Bancshares, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that First Mid Bancshares, Inc. is a Sell and believe this share price will drop from its current level to $39.00.
The price target for First Mid Bancshares, Inc. over the next 1-year time period is forecast to be $44.29 according to 5 Wall Street analysts, 2 of them rate the stock a Buy, 0 rate the stock a Sell, and 3 analysts rate the stock a Hold.
According to Wall Street analysts, the consensus rating for First Mid Bancshares, Inc. is a Hold. 3 of 5 analysts rate the stock a Hold at this time.
You can purchase shares of First Mid Bancshares, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase First Mid Bancshares, Inc. shares.
First Mid Bancshares, Inc. was last trading at $39.95 per share. This represents the most recent stock quote for First Mid Bancshares, Inc.. Yesterday, First Mid Bancshares, Inc. closed at $39.85 per share.
In order to purchase First Mid Bancshares, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Signup to receive the latest stock alerts
Following a bidding war, Netflix (NASDAQ:NFLX) has announced its intention…
Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…
Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…
Market Cap: $4.4T
P/E Ratio: 62x
Market Cap: $4.1T
P/E Ratio: 37x
Market Cap: $3.9T
P/E Ratio: 40x
SMX (Security Matters) Plc [SMX] is down 59.64% over the past day.
Kymera Therapeutics, Inc. [KYMR] is up 41.67% over the past day.
Praxis Precision Medicines, Inc. [PRAX] is up 9.18% over the past day.